Senti Biosciences Holdings, Inc. (SNTI) Return on equity 2022–2025
Senti Biosciences Holdings, Inc. (SNTI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1099.3%FY2025 · since FY2022: -45.7% → -1099.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1099.3% | -893.4 pp |
| FY2024 | -205.8% | -99.6 pp |
| FY2023 | -106.2% | -60.5 pp |
| FY2022 | -45.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SNTI financial trends
SNTI RevenueSNTI Net incomeSNTI Net marginSNTI Gross profitSNTI Gross marginSNTI Operating incomeSNTI Operating marginSNTI Operating cash flowSNTI Free cash flowSNTI Capital expendituresSNTI Stock buybacksSNTI Dividends paidSNTI Total assetsSNTI Total liabilitiesSNTI Shareholders’ equitySNTI overview →